43 related articles for article (PubMed ID: 17562067)
1. Blepharospasm and periorbital edema after imatinib mesylate: improvement with botulinum toxin.
Teive HAG; Germiniani FMB; Munhoz RP; Camargo CHF
Arq Neuropsiquiatr; 2020 Jan; 78(1):58-59. PubMed ID: 32074181
[No Abstract] [Full Text] [Related]
2. Bilateral macular oedema secondary to docetaxel treatment.
March de Ribot F; Jirapanyayut P; March de Ribot A
N Z Med J; 2024 Jun; 137(1596):94-98. PubMed ID: 38843553
[No Abstract] [Full Text] [Related]
3. Siponimod-Related Bilateral Macular Edema: A Transient and Completely Reversible Disorder.
Miscioscia A; Rinaldi F; Pilotto E; Perini P; Gallo P
J Neuroophthalmol; 2024 Mar; 44(1):e6-e7. PubMed ID: 36728552
[No Abstract] [Full Text] [Related]
4. Late Presentation of Pseudophakic Macula Edema from Oral Kinase Inhibitors: A Case Series and Literature Review.
Raj C; Levitz L
Case Rep Ophthalmol; 2024; 15(1):15-22. PubMed ID: 38187930
[TBL] [Abstract][Full Text] [Related]
5. Ocular Toxicity of Targeted Anticancer Agents.
Fortes BH; Tailor PD; Dalvin LA
Drugs; 2021 May; 81(7):771-823. PubMed ID: 33788182
[TBL] [Abstract][Full Text] [Related]
6. Neuro-ophthalmic side effects of molecularly targeted cancer drugs.
Bhatti MT; Salama AKS
Eye (Lond); 2018 Feb; 32(2):287-301. PubMed ID: 29052609
[TBL] [Abstract][Full Text] [Related]
7. Intravitreal bevacizumab and triamcinolone for treatment of cystoid macular oedema associated with chronic myeloid leukaemia and imatinib therapy.
Newcott EK; Ellabban AA; Tavassoli S; Sallam A
Case Rep Ophthalmol Med; 2015; 2015():713868. PubMed ID: 25722906
[TBL] [Abstract][Full Text] [Related]
8. Drug-induced macular edema.
Makri OE; Georgalas I; Georgakopoulos CD
Drugs; 2013 Jun; 73(8):789-802. PubMed ID: 23640687
[TBL] [Abstract][Full Text] [Related]
9. Periorbital edema secondary to imatinib mesylate.
McClelland CM; Harocopos GJ; Custer PL
Clin Ophthalmol; 2010 May; 4():427-31. PubMed ID: 20505834
[TBL] [Abstract][Full Text] [Related]
10. Bilateral masculine mastoplasia associated with imatinib mesylate: a case report and literature review.
Zhao D; Wang G; Li C; Meng L
J Huazhong Univ Sci Technolog Med Sci; 2011 Feb; 31(1):145-146. PubMed ID: 21336741
[No Abstract] [Full Text] [Related]
11. Imatinib induced Stevens-Johnson syndrome: lack of recurrence following re-challenge with a lower dose.
Pavithran K; Thomas M
Indian J Dermatol Venereol Leprol; 2005; 71(4):288-9. PubMed ID: 16394445
[No Abstract] [Full Text] [Related]
12. Bilateral cystoid macular edema in a patient with chronic myeloid leukaemia under treatment with imanitib mesylate: report of an unusual side effect.
Georgalas I; Pavesio C; Ezra E
Graefes Arch Clin Exp Ophthalmol; 2007 Oct; 245(10):1585-6. PubMed ID: 17562067
[No Abstract] [Full Text] [Related]
13. Imatinib as a cause of cystoid macular edema following uneventful phacoemulsification surgery.
Masood I; Negi A; Dua HS
J Cataract Refract Surg; 2005 Dec; 31(12):2427-8. PubMed ID: 16473243
[TBL] [Abstract][Full Text] [Related]
14. Unusual fluid retention with imatinib therapy for chronic myeloid leukemia.
Ostro D; Lipton J
Leuk Lymphoma; 2007 Jan; 48(1):195-6. PubMed ID: 17325868
[No Abstract] [Full Text] [Related]
15. Imatinib for chronic myeloid leukaemia: a NICE mess.
Lim D; Muir J
Lancet; 2001 Dec; 358(9296):1903. PubMed ID: 11741656
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
